- Home
- SABR vs PRME Comparison
SABR vs PRME Comparison
Compare SABR & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SABR | PRME |
|---|---|---|
| Founded | 2006 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Medicinal Chemicals and Botanical Products |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 652.0M | 666.1M |
| IPO Year | 2014 | 2022 |
Fundamental Metrics
Financial Performance| Metric | SABR | PRME |
|---|---|---|
| Price | $1.59 | $3.72 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 6 |
| Target Price | $3.70 | ★ $7.56 |
| AVG Volume (30 Days) | ★ 15.3M | 2.4M |
| Earning Date | 01-01-0001 | 06-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 283.56 | 18.18 |
| EPS | ★ 1.34 | N/A |
| Revenue | ★ $3,866,956,000.00 | $4,632,000.00 |
| Revenue This Year | $7.40 | $15.20 |
| Revenue Next Year | $3.26 | $316.23 |
| P/E Ratio | $1.27 | ★ N/A |
| Revenue Growth | 7.46 | ★ 55.28 |
| 52 Week Low | $0.81 | $1.11 |
| 52 Week High | $3.63 | $6.94 |
Technical Indicators
Market Signals| Indicator | SABR | PRME |
|---|---|---|
| Relative Strength Index (RSI) | 56.61 | 46.49 |
| Support Level | $1.20 | $3.19 |
| Resistance Level | $1.70 | $4.66 |
| Average True Range (ATR) | 0.21 | 0.28 |
| MACD | 0.01 | -0.05 |
| Stochastic Oscillator | 62.84 | 12.56 |
Price Performance
Historical ComparisonAbout SABR Sabre Corporation
Sabre holds the number-two air booking volume share in the global distribution system industry. The distribution segment represented 80% of total 2025 revenue and airline IT solutions 20% of revenue. The company sold its growing hotel IT solutions division to TPG in 2025 for $960 million in net proceeds. Transaction fees, which are mostly tied to volume and not price, account for the bulk of sales and profits.
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.